grazoprevir/elbasvir (GZR/EBR)

FDA approved for use in HIV/HCV co-infection
  • 1
  • 4

Standard Dose

One tablet once daily with or without food. Each tablet contains 100 mg of grazoprevir and 50 mg of elbasvir. The number of weeks on treatment depends on genotype, previous therapy, and presence of NS5A polymorphisms (mutations that may make the Zepatier less effective). Ribavirin may also be added in patients with certain baseline NS5A polymorphisms. See treatment duration tables at positivelyaware.com/drug-guides/zepatier.

Take missed dose as soon as possible unless it is less than 12 hours until your next dose. Do not double up on your next dose.




$8,736 / month

Potential Side Effects and Toxicity

Potential Drug Interactions

More Information